Liverpool Drug Interactions Group (03/04/2020). Evaluating the drug-drug interaction risk of experimental COVID-19 therapies Tratamientos e interacciones farmacológicas / 23 de Abril del 2020 Read more
Kampf et al. (2020). Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Características del virus / 23 de Abril del 2020 Read more
Chen et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Epidemiología / 23 de Abril del 2020 Read more
Chinazzi et al. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak Epidemiología / 23 de Abril del 2020 Read more
Munster et al. (2020). A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment Epidemiología / 23 de Abril del 2020 Read more
Van Doremalen, N., et al. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Características del virus / 23 de Abril del 2020 Read more
Rossetti et al. (2020). High Dose Of Ascorbic Acid Used In Sars Covid-19 Treatment: Scientific And Clinical Support For Its Therapeutic Implementation Tratamientos e interacciones farmacológicas / 23 de Abril del 2020 Read more
Phan et al. (2020). Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam Epidemiología / 23 de Abril del 2020 Read more
Huang et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Sintomatología / 23 de Abril del 2020 Read more
Ministerio de Sanidad (15/03/2020). Procedimiento de actuación frente a casos de infección por el nuevo coronavirus (sARS-CoV-2) Pruebas diagnósticas / 23 de Abril del 2020 Read more